Clinical Trial Update: Aripiprazole for Bipolar Disorder and Alcohol Use Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial of aripiprazole for bipolar disorder with alcohol use disorder has completed and results were posted on 2024-09-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Bipolar Disorder, Alcoholism | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19